ANTHONY A. CURRO JOINS COMPUMEDICS USA AS VICE PRESIDENT OF SALES, AMERICAS
El Paso TX, David Burton, Chairman of the Board and Chief Executive Officer of Compumedics Limited. (ASX:CMP), today announced that Mr. Anthony A. Curro has joined the Compumedics USA organization as the VP of Sales.
El Paso TX.-for immediate release, June 8th, 2005 — David Burton, Chairman of the Board and Chief Executive Officer of Compumedics Limited. (ASX:CMP), today announced that Mr. Anthony A. Curro has joined the Compumedics USA organization as the VP of Sales. “I am pleased to announce that Tony Curro has joined our organization. Tony brings over 20 years of sales, marketing and executive management skills to our company. His vast experience with a broad range of products in Cardiology, Respiratory and Sleep Diagnostics is a strong complement to our expanding portfolio and positions us for continued double digit growth in the US medical market place.”
Tony joins Compumedics from Guidant Corporation where he most recently headed up the Market Development Group in the Northeast USA, responsible for 38 employees generating over 500 Million dollars in annual sales. Tony has held various leadership positions in Sales and Marketing within the medical device industry throughout his career, and has established a proven track record producing consistent sales growth, while achieving overall corporate margin goals and profit and loss targets.
In these roles Tony has significantly over-achieved plans and consistently grown revenues at rates consistent with Compumedics historical annual growth rates of greater than 30%. In addition to his Guidant leadership, Tony’s experience in building high performance sales teams include both small start up and established medium size companies.
Compumedics was founded in 1987 by current Executive Chairman and CEO David Burton. In that year it established Australia’s first fully computerised sleep diagnostics clinic at Melbourne’s Epworth Hospital. In 1995 the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind currently exceeding 12,000 studies with 20,000 patients scheduled by 2008.
In 2002 the Company acquired US Based NeuroScan boosting its presence in the neuro diagnostics market, where the company supplies EEG and EMG devices to study electrical activity in the brain, spinal cord, nerves and muscles in the diagnosis and monitoring of neurological based diseases.
In 2004, Compumedics acquired German based DWL, enabling Compumedics to expand its global operations into the neuro-vascular and cardio-vascular diagnostic arenas.
Since the 2000 financial year, the company has increased sales four fold, reflecting product development initiatives combined with a strong United States distribution network which accounts for 55% of sales.
The company’s core sleep diagnostics technology is now being leveraged into the associated fields of neuro diagnostics, brain research and blood flow measurement. Combined, these markets have annual sales of more than USD900m. Compumedics also has businesses in supplies, technical service and educational services. Compumedics equipment is distributed in 60 countries globally. Headquarters are based in Melbourne Australia with offices in Germany, Singapore, Japan and the USA. Additional information can be obtained by visiting our website at www.compumedics.com
Chief Executive Officer
Ph: + 61 3 8420 7300
Chief Financial Officer & Company Secretary
Ph: + 1 915 225 0319